+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Artificial Blood Substitutes Market 2021-2025

  • PDF Icon

    Report

  • 120 Pages
  • February 2021
  • Region: Global
  • TechNavio
  • ID: 5264314
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Artificial Blood Substitutes Market 2021-2025

The publisher has been monitoring the artificial blood substitutes market and it is poised to grow by $ 7.38 bn during 2021-2025, progressing at a CAGR of 23% during the forecast period. The reports on artificial blood substitutes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing funding for product development, presence of large patient pool with intraoperative complications, and chronic blood donor shortage. In addition, increasing funding for product development is anticipated to boost the growth of the market as well.

The artificial blood substitutes market analysis includes product segment and geographical landscapes.

The artificial blood substitutes market is segmented as below:

By Product
  • HBOC
  • PFBOC

By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW

This study identifies the presence of large patient pool with intraoperative complications as one of the prime reasons driving the artificial blood substitutes market growth during the next few years.

The report on artificial blood substitutes market covers the following areas:
  • Artificial blood substitutes market sizing
  • Artificial blood substitutes market forecast
  • Artificial blood substitutes market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading artificial blood substitutes market vendors that include Aurum Biosciences Ltd., Hemarina SA, Hemoglobin Oxygen Therapeutics LLC, KaloCyte Inc., NuvOx Pharma LLC, and SpheriTech Ltd. Also, the artificial blood substitutes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • HBOC - Market size and forecast 2020-2025
  • PFBOC - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Vendor landscape
  • Landscape disruption
  • Competitive scenario

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Aurum Biosciences Ltd.
  • Hemarina SA
  • Hemoglobin Oxygen Therapeutics LLC
  • KaloCyte Inc.
  • NuvOx Pharma LLC
  • SpheriTech Ltd.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibit
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • HBOC - Market size and forecast 2020-2025 ($ million)
  • HBOC - Year-over-year growth 2020-2025 (%)
  • PFBOC - Market size and forecast 2020-2025 ($ million)
  • PFBOC - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Aurum Biosciences Ltd. - Overview
  • Aurum Biosciences Ltd. - Product and service
  • Aurum Biosciences Ltd. - Key offerings
  • Aurum Biosciences Ltd. - Key customers
  • Aurum Biosciences Ltd. - Segment focus
  • Hemarina SA - Overview
  • Hemarina SA - Product and service
  • Hemarina SA - Key offerings
  • Hemarina SA - Key customers
  • Hemarina SA - Segment focus
  • Hemoglobin Oxygen Therapeutics LLC - Overview
  • Hemoglobin Oxygen Therapeutics LLC - Product and service
  • Hemoglobin Oxygen Therapeutics LLC - Key offerings
  • Hemoglobin Oxygen Therapeutics LLC - Key customers
  • Hemoglobin Oxygen Therapeutics LLC - Segment focus
  • KaloCyte Inc. - Overview
  • KaloCyte Inc. - Product and service
  • KaloCyte Inc. - Key offerings
  • KaloCyte Inc. - Key customers
  • KaloCyte Inc. - Segment focus
  • NuvOx Pharma LLC - Overview
  • NuvOx Pharma LLC - Product and service
  • NuvOx Pharma LLC - Key offerings
  • NuvOx Pharma LLC - Key customers
  • NuvOx Pharma LLC - Segment focus
  • SpheriTech Ltd. - Overview
  • SpheriTech Ltd. - Product and service
  • SpheriTech Ltd. - Key offerings
  • SpheriTech Ltd. - Key customers
  • SpheriTech Ltd. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global artificial blood substitutes market: Aurum Biosciences Ltd., Hemarina SA, Hemoglobin Oxygen Therapeutics LLC, KaloCyte Inc., NuvOx Pharma LLC, and SpheriTech Ltd.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is presence of large patient pool with intraoperative complications.'

According to the report, one of the major drivers for this market is the increasing funding for product development.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aurum Biosciences Ltd.
  • Hemarina SA
  • Hemoglobin Oxygen Therapeutics LLC
  • KaloCyte Inc.
  • NuvOx Pharma LLC
  • SpheriTech Ltd.